UBS Group’s Aethlon Medical AEMD Stock Holding History

UBS Group’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.3K	Buy	1,775 +1,596	+892%	+$16.5K	﹤0.01%	8771
2026 Q1	$1.96K	Buy	+179	New	+$2.04K	﹤0.01%	9391
2025 Q3	–	Sell	-33	Closed	-$1.96K	–	10291
2025 Q2	$1.96K	Sell	33 -134	-80%	-$18K	﹤0.01%	9541
2025 Q1	$23.9K	Sell	167 -457	-73%	-$106K	﹤0.01%	8107
2024 Q4	$215K	Buy	624 +78	+14%	+$13.2K	﹤0.01%	6406
2024 Q3	$102K	Buy	546 +542	+13,550%	+$86.1K	﹤0.01%	6353
2024 Q2	$863	Buy	+4	New	+$1.58K	﹤0.01%	8756
2024 Q1	–	Hold	0	–	–	–	8715
2023 Q4	–	Sell	-1	Closed	-$711	–	8886
2023 Q3	$869	Hold	1	–	–	﹤0.01%	8239
2023 Q2	$1.14K	Sell	1 -2	-67%	-$2.93K	﹤0.01%	8003
2023 Q1	$4.76K	Buy	+3	New	+$5.65K	﹤0.01%	8151
2022 Q4	–	Sell	-3	Closed	-$5.47K	–	10332
2022 Q3	$7K	Buy	+3	New	+$13K	﹤0.01%	8838
2022 Q2	–	Hold	0	–	–	–	9802
2022 Q1	–	Sell	-1	Closed	-$5.97K	–	9828
2021 Q4	$8K	Buy	+1	New	+$11.4K	﹤0.01%	9010
2021 Q3	–	Hold	0	–	–	–	8923
2021 Q2	–	Sell	-3	Closed	-$34.5K	–	8305
2021 Q1	$21K	Buy	3 +2	+200%	+$19.2K	﹤0.01%	7328
2020 Q4	$8K	Buy	+1	New	+$6.68K	﹤0.01%	7608
2020 Q3	–	Sell	-1	Closed	-$6.77K	–	7623
2020 Q2	$10K	Hold	1	–	–	﹤0.01%	6995
2020 Q1	$7K	Buy	+1	New	+$8.46K	﹤0.01%	7122
2019 Q4	–	Hold	0	–	–	–	7915
2019 Q3	–	Hold	0	–	–	–	7715
2019 Q2	–	Hold	0	–	–	–	7825
2019 Q1	–	Hold	0	–	–	–	7517
2018 Q4	–	Hold	0	–	–	–	7613
2018 Q2	–	Hold	0	–	-$3K	–	7945
2018 Q1	–	Hold	0	–	–	–	7404
2017 Q4	–	Hold	0	–	–	–	7688
2017 Q3	–	Hold	0	–	–	–	7381
2017 Q2	–	Hold	0	–	–	–	6895
2017 Q1	–	Hold	0	–	–	–	7156
2016 Q4	–	Hold	0	–	–	–	6908
2016 Q3	–	Hold	0	–	–	–	7500
2016 Q2	–	Hold	0	–	–	–	6448
2016 Q1	–	Hold	0	–	–	–	7409
2015 Q4	–	Hold	0	–	–	–	8124
2015 Q3	–	Hold	0	–	–	–	7399

Other funds holding AEMD

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's AEMD Position: Q2 2026 in Review

UBS Group increased its Aethlon Medical (AEMD) stake by 892% in Q2 2026, buying an estimated $16.5K and bringing the position to 1,775 shares worth $7.3K. The position accounts for ﹤0.01% of the portfolio, ranked #8771.

UBS Group first reported a position in AEMD in Q1 2020 and has held it in 16 quarters since. The position peaked at $215K in Q4 2024. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

UBS Group held 1,775 shares of Aethlon Medical worth $7.3K as of Q2 2026.
UBS Group bought 1,596 Aethlon Medical shares in Q2 2026, an estimated $16.5K.
Aethlon Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8771 holding.
UBS Group first reported a position in Aethlon Medical in Q1 2020 and has held it in 16 quarters since.
UBS Group's Aethlon Medical position peaked at $215K in Q4 2024.
15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.